The other opinion: nephrotoxicity of low-dose methotrexate - a problem which does not exist

被引：0
作者：
Fiehn, C. [1 ]
机构：
[1] ACURA Rheumazentrum Baden Baden, CH-76530 Baden, Switzerland
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2011年 / 70卷 / 10期
关键词：
Methotrexate; Nephrotoxicity; Renal function; Dose-dependency; Non-steroidal antirheumatic agents; RHEUMATOID-ARTHRITIS; DRUG; THERAPY;
D O I：
10.1007/s00393-011-0909-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The nephrotoxicity of methotrexate (MTX) is a phenomenon which is observed in high-dose therapy for treatment of malignant diseases. Even low-dose MTX therapy for treatment of rheumatic diseases is claimed to cause impairment in renal function. The necessity to adapt the dosage of MTX therapy for renal function disorders due to other causes however has first priority. The following article describes why nephrotoxicity of low-dose MTX has no clinical relevance and why in contrast non-steroidal anti-rheumatic drugs (NSARDs) are a problematic nephrotoxic group of substances and a long-term elimination from the therapeutic armamentarium for rheumatoid arthritis (RA) should be instigated.
引用
收藏
页码：825 / 826
页数：2
相关论文
共 50 条
  • [1] The Other Opinion: Nephrotoxizität von niedrig dosiertem Methotrexat – ein Problem, das keines istThe other opinion: nephrotoxicity of low-dose methotrexate – a problem which does not exist
    C. Fiehn
    Zeitschrift für Rheumatologie, 2011, 70 (10) : 825 - 826
  • [2] Nephrotoxicity of low-dose methotrexate in guinea pigs: An ultrastructural study
    ElBadawi, MG
    Abdalla, MA
    Bahakim, HM
    Fadel, RA
    NEPHRON, 1996, 73 (03): : 462 - 466
  • [3] Does low-dose methotrexate deserve more respect from clinicians?
    Luu, Brent
    Rodway, George W.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (05): : 12 - 15
  • [4] Usefulness of Low-dose Methotrexate Monotherapy for Treating Sarcoidosis
    Isshiki, Takuma
    Yamaguchi, Tetsuo
    Yamada, Yoshihito
    Maemura, Keita
    Makita, Kosuke
    Takeshima, Hideyuki
    Hirasawa, Yasutaka
    Yamaguchi, Yoko
    Hosoki, Keisuke
    Suzuki, Mika
    Kono, Chiyoko
    Terada, Jiro
    Tatsumi, Koichiro
    INTERNAL MEDICINE, 2013, 52 (24) : 2727 - 2732
  • [5] Pharmacokinetics of low-dose methotrexate in horses
    Rostang, Antoine
    Desjardins, Isabelle
    Espana, Bernadette
    Panzuti, Pauline
    Berny, Philippe
    Prouillac, Caroline
    Pin, Didier
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2020, 43 (05) : 461 - 469
  • [6] Leukoencephalopathy Induced by Low-dose Methotrexate in a Patient with Rheumatoid Arthritis
    Matsuda, Masayuki
    Kishida, Dai
    Kinoshita, Tomomi
    Hineno, Akiyo
    Shimojima, Yasuhiro
    Fukushima, Kazuhiro
    Ikeda, Shu-ichi
    INTERNAL MEDICINE, 2011, 50 (19) : 2219 - 2222
  • [7] LOW-DOSE CYCLOSPORINE NEPHROTOXICITY IN THE RAT
    FERGUSON, CJ
    VONRUHLAND, C
    PARRYJONES, DJ
    GRIFFITHS, DFR
    SALAMAN, JR
    WILLIAMS, JD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (11) : 1259 - 1263
  • [8] Leukoencephalopathy associated with low-dose oral methotrexate
    Nakayama, Sachiko
    Hatano, Taku
    Kubo, Shin-Ichiro
    Mori, Akio
    Hattori, Nobutaka
    Yamada, Yusuke
    Ogasawara, Michihiro
    Tamura, Naoto
    Takasaki, Yoshinari
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2013, 1 (03): : 128 - 129
  • [9] Fatal Pancytopenia in a Hemodialysis Patient After Treatment With Low-Dose Methotrexate
    Cheung, Kitty Kit Ting
    Chow, Kai Ming
    Szeto, Cheuk Chun
    Tai, Morris Hok Leung
    Kwan, Bonnie Ching Ha
    Li, Philip Kam Tao
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2009, 15 (04) : 177 - 180
  • [10] Fatal low-dose methotrexate toxicity: A case report and literature review
    Ouellette, Samantha
    Shah, Rohan
    Razi, Shazli
    Ashforth, Gina
    Wassef, Cindy
    DERMATOLOGIC THERAPY, 2022, 35 (12)
12345